Psychiatry AdvisorDialectical Behavior Therapy Reduces Symptoms in Borderline Personality Disorder

A randomized controlled trial in The American Journal of Psychiatry found DBT reduced suicide-related events by 71% versus SSRI therapy during active 6-month treatment in adults with BPD and recent self-harm history. The 84-patient cohort presented with severe baseline risk: 71% had prior suicide attempts and 93% reported NSSI history.

🧠 Clinical Considerations

• DBT produced 3x fewer suicide attempts than SSRIs during treatment (RR 0.32; p=.048), with meaningfully lower NSSI frequency
• Impulsivity and emotion dysregulation improved faster with DBT, though these gains did not independently drive suicide risk reduction
• MDD remission favored SSRIs (26% vs 3%), suggesting combination approaches warrant evaluation for comorbid patients
• Treatment gains did not persist at 12 months, raising critical questions about maintenance therapy and step-down protocols

🎯 Practice Applications

• Prioritize DBT over SSRI monotherapy for BPD patients with active suicidal behavior or recent NSSI
• Plan maintenance interventions before DBT completion to prevent post-treatment risk rebound
• Monitor comorbid MDD separately; SSRIs remain superior for depressive remission in this population
• Document baseline suicide attempt history and NSSI frequency to establish measurable treatment benchmarks

More in Personality Disorders